The Chronicle has often reported on the total mess Texas has made with its cannabis laws and regulations since finally in 2019 the step was taken to create a legal hemp industry in the state. Almost immediately after House Act 1325 came into force in June of that year, it became clear that most Texas police and prosecutors could not prove the difference between cannabis low in THC (below 0). , 3% of the concentration of delta-9-tetrahydrocannabinol in dry weight.), Which is legal “hemp” or “industrial hemp” under federal and state laws, and cannabis with more THC still known in the Texas statute as “marijuana.” This led to the de facto decriminalization of possession of small amounts of cannabis in much of the state, made more intentional in cities like Austin that directed their police forces to end the application.
Both HB 1325 and the 2018 federal agricultural law, which for the first time considered hemp with a low THC content as a legal agricultural product, include provisions aimed at drawing bright lines between legal and illegal cannabis production. Texas law states that producers and producers licensed by the Texas Department of Agriculture may not process or manufacture hemp for smoking or vaporizing.
However, it is less prescriptive in terms of the consumer market for hemp products that contain cannabinoids such as CBD (cannabidiol, the most common in both the market and the hemp plant) or Delta-8-THC. Instead, HB 1325 instructs the State Department of Health Services to develop a regulatory scheme for distributors and retailers. When DSHS launched its Consumable Hemp Program in August 2020, it excluded any hemp product intended to be smoked or vaporized. A group of retailers, with the support of the industry, immediately and successfully sued to prevent this rule from coming into force, arguing how their Delta-8 colleagues have done that the status quo market works well and that DSHS exceeded its limits.
In the case of smokable hemp, the plaintiffs noted that the distinctions between product types (smoke, vaporization, tincture, edible, and more) no longer have much influence on a cannabis industry that can produce all of this with different concentrations of different cannabinoids to satisfy the consumer. preferences. The Delta-8 dispute represents a next phase in this evolution and another dilemma for a conservative state regime that wants to make cannabis legal (and profitable) and illegal (and severely punished) at the same time.
While Texas Agriculture Commissioner Sid Miller, a major proponent of the industry, views hemp as a perfectly mundane fiber crop, as does cotton: “We’re growing rope, not drugs,” the money that s ‘are gaining at the moment come from cannabinoid products like CBD. oil, which can be converted in the laboratory into Delta-8. As DSHS struggles to maintain the state’s quixotic stance on cannabis, the U.S. Food and Drug Administration is frantically trying to keep up with the boom in CBD and Delta-8 amid supplements, pharmaceuticals , cosmetics and food additives it regulates. While the FDA warns consumers that neither Delta-8 nor CBD products have been evaluated for safety or efficacy, and has issued some warnings to companies making unfounded health claims, “the potential [therapeutic] opportunities that cannabis or cannabis-derived compounds can offer and recognizes the significant interest in these possibilities, “according to its website. Because drugs that include CBD and THC are going through or have completed the approval process of drugs, these cannabinoids cannot, under federal law, be marketed as dietary supplements or added to human or animal foods, although the FDA has shown little interest in the application.
